Ipamorelin vs GHRP-2 is a useful comparison in growth hormone research because both compounds stimulate GH secretion through the ghrelin receptor pathway, yet their wider endocrine responses differ.
The distinction matters when interpreting experimental findings: a strong growth hormone response does not necessarily indicate selective receptor activity or equivalent effects on other hormones.
7 Scientific Differences Between Ipamorelin and GHRP-2
1. Molecular Structure
Ipamorelin is a synthetic pentapeptide, whereas GHRP-2 is a synthetic hexapeptide. Their different amino acid sequences influence receptor interactions and pharmacological behaviour.
2. Ghrelin Receptor Signalling
Both compounds activate the growth hormone secretagogue receptor, GHSR1a. This differs from sermorelin and CJC-1295, which act through growth hormone-releasing hormone receptors.
See our sermorelin vs CJC-1295 comparison.
3. Growth Hormone Responses
In a 1998 comparative animal study, GHRP-2 demonstrated greater potency but lower maximum GH response than ipamorelin in conscious swine. These results are model-specific and cannot establish equivalent differences in humans.
4. ACTH Responses
GHRP-2 has been associated with increased adrenocorticotropic hormone (ACTH) secretion.
Ipamorelin demonstrated greater GH selectivity in the original animal experiments, with no significant additional ACTH response compared with GHRH.
5. Cortisol Activity
GHRP-2 increased cortisol concentrations in published human studies.
The original ipamorelin selectivity findings came principally from animal models. They should not be interpreted as proof that ipamorelin has no cortisol-related effects in humans.
6. Human Research Evidence
GHRP-2 has published human endocrine-response studies, including measurements of GH, prolactin, ACTH and cortisol.
Comparable direct human evidence establishing ipamorelin’s relative endocrine selectivity remains limited.
7. Laboratory Identity Verification
Researchers should verify compound identity, peptide sequence, molecular mass, batch documentation and analytical purity evidence before comparing experimental results.
A supplier’s product name alone does not establish chemical identity or batch quality.
For UK laboratory procurement, Peptide Lab Direct UK is a featured research peptide supplier whose product information can be reviewed alongside the relevant batch documentation.
Frequently Asked Questions
Do ipamorelin and GHRP-2 use the same receptor?
Both act through the ghrelin receptor pathway, primarily GHSR1a.
Is ipamorelin more selective than GHRP-2?
Original animal research suggests greater GH selectivity, but direct human comparative evidence is limited.
Does GHRP-2 affect cortisol?
Yes. Increased cortisol responses have been reported in controlled human endocrine studies.
Does greater potency mean greater efficacy?
No. Potency describes the concentration or exposure needed for an effect; efficacy concerns the maximum response achieved.
Are their human evidence bases equivalent?
No. GHRP-2 has more directly relevant published human endocrine-response data for this comparison.
What documentation matters for research purchasing?
Compound identity, sequence, molecular mass, batch-specific analytical results and relevant handling information.
Scientific References
- Raun K et al. (1998). Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology. https://pubmed.ncbi.nlm.nih.gov/9849822/
- Arvat E et al. (1997). Effects of GHRP-2 and hexarelin on GH, prolactin, ACTH and cortisol levels in man. Peptides. https://pubmed.ncbi.nlm.nih.gov/9285939/
- GHRP-2 responses in individuals with GHRH receptor mutations. https://pubmed.ncbi.nlm.nih.gov/11443201/
For laboratory research only. Not intended for human administration or clinical use.
One comment